[Vanadium metabolism following supplementary administration of several microelements in experimental atherosclerosis].
D000818:Animals; D001011:Aorta / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism; D002682:Chinchilla; D002784:Cholesterol / Q000378:metabolism*; D003035:Cobalt / Q000627:therapeutic use; D003300:Copper / Q000627:therapeutic use; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008345:Manganese / Q000627:therapeutic use; D009132:Muscles / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D011817:Rabbits; D014131:Trace Elements / Q000627:therapeutic use*; D014639:Vanadium / Q000378:metabolism*; D015032:Zinc / Q000627:therapeutic use
D010743:Phospholipids; D014131:Trace Elements; D014639:Vanadium; D003035:Cobalt; D008345:Manganese; D003300:Copper; D002784:Cholesterol; D015032:Zinc
Obmen vanadiia pri dopolnitel'nom vvedenii v organizm nekotorykh mikroélementov na fone éksperimental'nogo ateroskleroza.